Diagnosis of cardiovascular disease in patients with chronic kidney disease

Area of Science:

• Nephrology
• Cardiology
• Clinical Diagnostics

Background:

• Patients with chronic kidney disease (CKD) exhibit a significantly elevated risk of cardiovascular disease (CVD) and associated mortality.
• Effective identification and monitoring of cardiovascular complications and hypertension are essential for managing CKD patients, including those with kidney failure and transplant recipients.

Purpose of the Study:

• To review and highlight the utility of various diagnostic techniques for detecting cardiovascular alterations in patients with chronic kidney disease.
• To emphasize the importance of judicious application of these diagnostic tools for timely intervention and management of CVD in high-risk CKD populations.

Main Methods:

• Evaluation of established and advanced diagnostic modalities for assessing myocardial ischemia, coronary artery disease, left ventricular abnormalities, and arrhythmias in CKD patients.
• Discussion of the limitations of traditional biomarkers like troponins and ECG in advanced CKD.
• Inclusion of advanced imaging and monitoring techniques such as dobutamine stress echocardiography, myocardial perfusion scintigraphy, ambulatory blood pressure monitoring, and heart rhythm monitoring.

Main Results:

• Standard biomarkers (troponins, ECG) have limited diagnostic value for cardiac ischemia in advanced CKD.
• Advanced imaging (echocardiography, CT, MRI, scintigraphy) and stress tests are effective for detecting coronary disease, left ventricular hypertrophy, and dysfunction.
• Ambulatory monitoring is key for diagnosing arrhythmias, while blood pressure monitoring is vital for hypertension management.

Conclusions:

• A comprehensive approach utilizing a range of diagnostic techniques is necessary to detect diverse cardiovascular alterations in CKD patients.
• Timely diagnosis and management of CVD in CKD patients through appropriate use of these diagnostics can significantly reduce cardiovascular morbidity and mortality.